FDA suggests lower doses on popular sleeping aid LunestaFDA suggests lower doses on popular sleeping aid LunestaThe Food and Drug Administration wants new curbs on yet another popular prescription sleep medication because of concerns that adults may still be driving drowsy the next day.Joe CutterJoe Cutter